U.S. Markets closed

Incyte Corporation (INCY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
121.19-0.55 (-0.45%)
At close: 4:00PM EDT

121.19 0.00 (0.00%)
After hours: 6:00PM EDT

People also watch
VRTXBMRNALXNREGNSGEN
  • A
    Anonymous
    Anonymous
    Thing about trading ranges--that's where the stock price is when nothing's happening. No need for an explanation of any move within the range. Now, in the last week we've had let's see...sharpest war scare in a few years, disappointing result of a competitor's IO drug combo trial, disassembly of US executive (with a pot-shot at drug pricing tweeted out), domestic terrorism, foreign terrorism.... And a lot of INCY is in "hot stock"-oriented portfolios, which are weak hands by definition. Seems like plenty of reasons for leaving the channel, all real and all unrelated to the actual business of Incyte.

    And for all that, INCY is still above the post-CRL low.
  • T
    Tom
    Tom
    selling into every rip, means cleaning out all those on margin
  • M
    Maddison
    Maddison
    OT..Please pray for the injured/deceased in Barcelona today... The barbaric terrorists in this world must not win!
  • D
    DQSjr
    DQSjr
    Still in our range and some interesting activity taking place Level II showing buying taking place on the drops.
    Have to believe until GILD makes/announces a purchase...INCY still a top contender and we ride that possibility. We might find someone else comes out and beats GILD to the punch. Until such time...watch the moves associated with "volume" and what is moving the price. Ignore Tommy...he only comes out on Red Days with nothing but agenda driven commentary.
  • A
    Anonymous
    Anonymous
    BMS has reported topline from a study of Opdivo + Yervoy (immunotherapy + checkpoint drug) against kidney cancer. In general, the combination was directionally better than BAT, but didn't reach statistical significance on the key progression-free survival endpoint (DID reach signicance on overall response rate). Overall survival looked good, but can't be interpreted yet. The study will continue; the combination will probably be used, but probably won't go on-label.

    This continues the pattern of immunotherapy + active agent giving unspectacular results. That is GOOD for peddlers of immunotherapy + booster combinations (ie, Incyte) where the results have sometimes been spectacular.

    However, this seems to be getting interpreted as a double-whammy (anyone else remember Evil-Eye Fleegle?) against Incyte--on the one hand, an IO drug combination disappointed / on the other hand, the combination is still probably an improvement and will raise the bar for epac. Do note that Yervoy has a substantial rate of serious AEs both on its own and in combinations. Epac's AEs are not generally regarded as serious.
  • w
    wereinayelllowsubmarine
    wereinayelllowsubmarine
    I guess it officially fell out of the Great Leader's estimate range when it broke below $122. But don't worry, I'm sure he'll give you another great post soon!
  • M
    Michael-P
    Michael-P
    INCY shares on sale again... Put on your seat belt. When the buyout comes one of these Mondays, that's when the longs are rewarded. My gut feeling is Gilead is indeed processing an offer and the CEO is doing whatever he can to squash speculation. i would think that this maybe brings the deal under 200 ppp (with bad luck bari delay), but Gilead would try to sell bari rights back to Lilly anyway, at least that's what one analyst had suggested. Hold on longs! Stay in your bunker. We appear to be experiencing BMS fallout. It is collateral damage, not INCY. First Korea, now this... kind of a double whammy. Will recover soon.
  • D
    DQSjr
    DQSjr
    We must be getting close to a deal...Tommy's negative posts have increased and he really comes out in force on down days. Is he anxious? Worried? Working for the group putting a deal together? Conspiracy? Nobody hangs around since the low teens getting hammered calling for a fall in SP this long. Who's buying INCY Tommy??
  • B
    B
    B
    Imagedxamaged
  • D
    DQSjr
    DQSjr

    Read the article for yourself as Tommy will only post to satisfy his own personal narrative!

    https://finance.yahoo.com/m/7073c7dc-fc6b-3075-8dbd-f9d84ffe0986/why-gilead-sciences-might-not.html

    Why Gilead Sciences Might Not Make an Oncology Acquisition
    Gilead Sciences' CEO hints that buying a biotech with an oncology focus might not happen. Here's what this could mean for the big biotech.
    finance.yahoo.com
  • M
    Maddison
    Maddison
    Baker Brothers own almost 20% of outstanding stock... Who knows more about biotech? Tommy or BB? Case closed!
  • M
    Michael-P
    Michael-P

    Gilead: Road To $100 -- From Seekingalpha

    "...Incyte makes a lot of sense and isn’t a ton of ‘risk’ in that it has an impressive portfolio and pipeline, much of which have plenty of overlap with Gilead’s existing products... Incyte is the long and steady play."

    https://seekingalpha.com/article/4100043-gilead-road-100?auth_param=1e7tqa:1cpdohc:1b0bc8d8f7c81398d02afcf133477c0d&uprof=45&dr=1#alt1

    Gilead: Road To $100
    Gilead might have an activist investor.Dan Loeb fits the mold.He’ll push for a buyout and there are two prime candidates.
    seekingalpha.com
  • D
    DQSjr
    DQSjr
    Evercore ISI Group "initiates" coverage at $135.00. Welcome aboard!!
  • T
    Tom
    Tom
    no bari approval USA or next 2 YEARS
    insider selling
    no insider buying EVER
    ASCO bust
    AARC BUST
    ASH BUST
    ruxo additional testing bust (pancreatic and solid tumor) (Alopecia)bust
    recent dropped studies, think it was epac
    buying shares in AGEN, not once but twice , double the BUST
    buying the shares in MRUS, bust

    gild buying incy a bust
    mrk and bmy stopped studies, a 4 times the BUST to INCYTE
    coverages initated, a bust
    added to the s and p index a bust
    Price target increases, a bust
    maddi giving his PT's when BB's list their shares 157 to 114 BUST
    maddi giving his PT on earnings of 140.......how low will it go , currently 121 BUST
    breakout under 200dma....BUST
    IBB still $14above 200DMA

    BUSTED, as options kill it ALL tomorrow
  • T
    Tom
    Tom
    I HAVE BEEN POUNDING THE TABLE, YOU ARE ALL BAGHOLDERS............SO GLAD MADDI, THINKS I AM FULL OF BS

    WHERE IS 140, STILL WAITING, TOMORROW SUB 120
  • M
    Maddison
    Maddison
    Tommy will NEVER admit that he was posting a few years ago... $19, $18, $17... we go down 10% from $135 and he thinks the sky is falling... it is not unique to INCY... just look at the overall market today...problems with terrorism, the #$%$ in WH.. I can go on but everyone on this MB knows it but Tommy...
  • B
    B
    B
    Imagecracked
  • T
    Tom
    Tom
    new coverage, incyte goes down, good job!!!!
  • T
    Tom
    Tom
    gild buying incyte 2 plus years long SPEWING this......not happening
  • T
    Tom
    Tom
    still waiting for 140, seems the price keeps going down